Article Source: msnbc.comfrom:msnbc.comFDA looks into blood pressure med death riskSeeded on Fri Jun 11, 2010 3:42 PM EDT (msnbc.com)Diabetes patients in two studies had higher death rates than control groups Permalink3 comments— Filed under: health, heart-health
Ray-1162980 Another pharm that kills and they say no problem. Who are we to believe, the research that shows a relationship to use and death. or the pharm that wants to sell drugs. 1 vote#1 - Sat Jun 12, 2010 12:48 AM EDTdebtfree-1174430 I certainly wouldn't want to be one of the few dead. I wonder if the ceo's of these companies actually use their own drugs.#2 - Sat Jun 12, 2010 7:27 AM EDTDr. LecterYou don’t need to take angiotensin II receptor blockers including Olmesartan. The days of the renin inhibitor, Aliskiren has come. It does not increase plasma renin activity. ARBs should be the 2nd choice.#3 - Thu Jun 17, 2010 10:02 PM EDTLeave a Comment:Name: Email Address (will be verified, but never shown): You're in Easy Mode. If you prefer, you can use XHTML Mode instead.You're in XHTML Mode. If you prefer, you can use Easy Mode instead.(XHTML tags allowed - a,b,blockquote,br,code,dd,dl,dt,del,em,h2,h3,h4,i,ins,li,ol,p,pre,q,strong,ul) Post to my Facebook Wall Newsvine Privacy StatementAs a new user, you may notice a few temporary content restrictions. Click here for more info.
Another pharm that kills and they say no problem. Who are we to believe, the research that shows a relationship to use and death. or the pharm that wants to sell drugs.
I certainly wouldn't want to be one of the few dead. I wonder if the ceo's of these companies actually use their own drugs.
You don’t need to take angiotensin II receptor blockers including Olmesartan.
The days of the renin inhibitor, Aliskiren has come.
It does not increase plasma renin activity.
ARBs should be the 2nd choice.